Sherli Koshy-Chenthittayil

Dr. Sherli Koshy-Chenthittayil

University of Connecticut Health Center
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
LALinda Archambault
Linda Archambault
DSDhananjai Senthilkumar
Dhananjai Senthilkumar
RLReinhard Laubenbacher
Reinhard Laubenbacher
PMPedro Mendes
Pedro Mendes
ADAnna Dongari-Bagtzoglou
Anna Dongari-Bagtzoglou
The human microbiome has been a focus of intense study in recent years. Most of the living organisms comprising the microbiome exist in the form of biofilms on mucosal surfaces lining our digestive, respiratory, and genito-urinary tracts. While health-associated microbiota contribute to digestion, provide essential nutrients, and protect us from pathogens, disturbances due to illness or medical interventions contribute to infections, some that can be fatal. Myriad biological processes influence the make-up of the microbiota, for example: growth, division, death, and production of extracellular polymers (EPS), and metabolites. Inter-species interactions include competition, inhibition, and symbiosis. Computational models are becoming widely used to better understand these interactions. Agent-based modeling is a particularly useful computational approach to implement the various complex interactions in microbial communities when appropriately combined with an experimental approach. In these models, each cell is represented as an autonomous agent with its own set of rules, with different rules for each species. In this review, we will discuss innovations in agent-based modeling of biofilms and the microbiota in the past five years from the biological and mathematical perspectives and discuss how agent-based models can be further utilized to enhance our comprehension of the complex world of polymicrobial biofilms and the microbiome.

26 August 2024 in JBI Evidence Synthesis
Verified
Journal Article
Open access
EHEllyn Hirabayashi
Ellyn Hirabayashi
GMGuadalupe Mercado
Guadalupe Mercado
BHBrandi Hull
Brandi Hull
SSSabrina Soin
Sabrina Soin
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
Amy E.L. StoneAmy E.L. Stone
Amy E.L. Stone
Objective: The objective of this review was to determine the diagnostic accuracy of the currently available and upcoming point-of-care rapid antigen tests (RATs) used in primary care settings relative to the viral genetic real-time reverse transcriptase polymerase chain reaction (RT-PCR) test as a reference for diagnosing COVID-19/SARS-CoV-2 in adults. Introduction: Accurate COVID-19 point-of-care diagnostic tests are required for real-time identification of SARS-CoV-2 infection in individuals. Real-time RT-PCR is the accepted gold standard for diagnostic testing, requiring technical expertise and expensive equipment that are unavailable in most primary care locations. RATs are immunoassays that detect the presence of a specific viral protein, which implies a current infection with SARS-CoV-2. RATs are qualitative or semi-quantitative diagnostics that lack thresholds that provide a result within a short time frame, typically within the hour following sample collection. In this systematic review, we synthesized the current evidence regarding the accuracy of RATs for detecting SARS-CoV-2 compared with RT-PCR. Inclusion criteria: Studies that included nonpregnant adults (18 years or older) with suspected SARS-CoV-2 infection, regardless of symptomology or disease severity, were included. The index test was any available SARS-CoV-2 point-of-care RAT. The reference test was any commercially distributed RT-PCR–based test that detects the RNA genome of SARS-CoV-2 and has been validated by an independent third party. Custom or in-house RT-PCR tests were also considered, with appropriate validation documentation. The diagnosis of interest was COVID-19 disease and SARS-CoV-2 infection. This review considered cross-sectional and cohort studies that examined the diagnostic accuracy of COVID-19/SARS-CoV-2 infection where the participants had both index and reference tests performed. Methods: The keywords and index terms contained in relevant articles were used to develop a full search strategy for PubMed and adapted for Embase, Scopus, Qinsight, and the WHO COVID-19 databases. Studies published from November 2019 to July 12, 2022, were included, as SARS-CoV-2 emerged in late 2019 and is the cause of a continuing pandemic. Studies that met the inclusion criteria were critically appraised using QUADAS-2. Using a customized tool, data were extracted from included studies and were verified prior to analysis. The pooled sensitivity, specificity, positive predictive, and negative predictive values were calculated and presented with 95% CIs. When heterogeneity was observed, outlier analysis was conducted, and the results were generated by removing outliers. Results: Meta-analysis was performed on 91 studies of 581 full-text articles retrieved that provided true-positive, true-negative, false-positive, and false-negative values. RATs can identify individuals who have COVID-19 with high reliability (positive predictive value 97.7%; negative predictive value 95.2%) when considering overall performance. However, the lower level of sensitivity (67.1%) suggests that negative test results likely need to be retested through an additional method. Conclusions: Most reported RAT brands had only a few studies comparing their performance with RT-PCR. Overall, a positive RAT result is an excellent predictor of a positive diagnosis of COVID-19. We recommend that Roche’s SARS-CoV-2 Rapid Antigen Test and Abbott’s BinaxNOW tests be used in primary care settings, with the understanding that negative results need to be confirmed through RT-PCR. We recommend adherence to the STARD guidelines when reporting on diagnostic data. Review registration: PROSPERO CRD42020224250

22 June 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BPBritta Petersen
Britta Petersen
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
MDMegan DeArmond
Megan DeArmond
LCLeslie A Caromile
Leslie A Caromile
Diversity enriches the educational experience by improving intellectual engagement, self-motivation, citizenship, cultural engagement, and academic skills like critical thinking, problem-solving, and writing for students of all races. Faculty role models from similar backgrounds are essential for students from traditionally underrepresented groups as it sends a powerful message of support, belonging, and the confidence to pursue higher education. However, in the biomedical sciences, the percentage of historically underrepresented tenure-track faculty is far lower than that of their white colleagues. For this to change, a strong strategic plan and commitment from the university are imperative. This scoping review will assess the size and scope of available peer-reviewed research literature on diversity programs that aim to increase the recruitment and retention of biomedical sciences research faculty and are implemented and evaluated at American Universities. The information provided in this scoping review will help universities identify novel, successful diversity-based approaches for recruiting and retaining biomedical science faculty that might suit their own unique academic and geographic needs and be incorporated into their diversity initiatives and policies. The review follows the Population-Concept-Context methodology for Joanna Briggs Institution Scoping Reviews. Relevant peer-reviewed studies published in English between June 1, 2012, to June 1, 2022, will be identified from the following electronic databases; MEDLINE (PubMed), Scopus (Elsevier), EMBASE (Elsevier), CINAHL (EBSCO), and ERIC (EBSCO). The search strings using the key variables “biomedical research faculty,” “recruitment/retention,” “diversity/ minority/ underrepresented, and “mentoring” will be conducted using Boolean logic. Two independent reviewers will conduct all title and abstract screening, followed by a full article screening and data extraction. Due to the possible heterogeneity of the studies, we hope to use either a narrative analysis and/or descriptive figures/tables to depict the results.

20 April 2023 in mSphere
Verified
Journal Article
Open access
LALinda Archambault
Linda Archambault
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
ATAngela Thompson
Angela Thompson
ADAnna Dongari-Bagtzoglou
Anna Dongari-Bagtzoglou
RLReinhard Laubenbacher
Reinhard Laubenbacher
PMPedro Mendes
Pedro Mendes
We previously discovered a role of the oral commensal Streptococcus oralis as an accessory pathogen. S. oralis increases the virulence of Candida albicans infections in murine oral candidiasis and epithelial cell models through mechanisms which promote the formation of tissue-damaging biofilms. Lactobacillus species have known inhibitory effects on biofilm formation of many microbes, including Streptococcus species. Agent-based modeling has great advantages as a means of exploring multifaceted relationships between organisms in complex environments such as biofilms.

29 August 2025 in Nurse Educator
Verified
Journal Article
Open access
JGJessica Grimm
Jessica Grimm
JAJulie Astrella
Julie Astrella
CCCatherine Chung
Catherine Chung
HJHeidi Johnston
Heidi Johnston
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
MKMarietta Kaloyan
Marietta Kaloyan

17 July 2020
Verified
Book Chapter
Closed access
PDF file
Sherli Koshy-ChenthittayilSherli Koshy-Chenthittayil
Sherli Koshy-Chenthittayil
EDElena Dimitrova
Elena Dimitrova